Christopher A. Toth - Jan 31, 2025 Form 4 Insider Report for BAXTER INTERNATIONAL INC (BAX)

Role
EVP, Group Pres, Kidney Care
Signature
/s/ Kimberly Olson, as attorney in fact for Christopher A. Toth
Stock symbol
BAX
Transactions as of
Jan 31, 2025
Transactions value $
-$826,112
Form type
4
Date filed
2/4/2025, 04:03 PM
Previous filing
Jan 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BAX Common Stock, $1 par value Tax liability -$826K -25.4K -19.43% $32.56 105K Jan 31, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Christopher A. Toth is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on January 31, 2025 from the settlement of restricted stock units granted on March 6, 2024. These shares vested on January 31, 2025 in accordance with the terms of that Equity Purchase Agreement, dated as of August 12, 2024 (as amended), by and among Baxter International Inc. and certain Carlyle affiliates (the "EPA").
F2 Adjusted to reflect (i) automatic reinvestment of dividends, and (ii) the number of shares forfeited by the reporting person in connection with the closing of the EPA, as further described in the Issuer's Form 8-K filed on February 3, 2025.